Albert David (ALBERTDAVD) | Stock Overview & Key Data
Albert David Performance Comparison
Stock Range
Today's Range
Low: ₹782.40
High: ₹808.15
on October 8, 2025
52 Week Range
Low: ₹762.60
High: ₹1,540.00
on April 7, 2025
on December 11, 2024
All-Time High: ₹1,753.95 on September 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR4.6B
EPS
11.00
P/E Ratio (TTM)
71.19
Forward P/E
N/A
P/B Ratio
1.14
PEG Ratio
-1.23
Div. Yield
1.86%
ROE
4.38%
Beta
0.041
Debt to Equity
3.14
Financial Highlights
Profitability
Gross Margin
64.18%
Operating Margin
-18.48%
Profit Margin
1.93%
Returns and Earnings
Return on Assets (TTM)
3.36%
Return on Equity (TTM)
4.38%
EBITDA
INR133.1M
Net Income (TTM)
INR62.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR572.93
Quarterly Revenue Growth (YoY)
-21.00%
Quarterly Earnings Growth (YoY)
-57.90%
Dividend Information
Last 12-Month Dividend
₹16.50
Current Dividend Yield
1.86%
3-Year Average Dividend Yield
1.16%
3-Year Average Annual Dividend
₹17.50
3-Year Total Dividends
₹52.50
Ex-Dividend Date
July 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Albert David ALBERTDAVD | 4.56B Small-cap | 0.54% | -1.79% | -14.96% | 0.45% | -41.40% | -44.97% | 39.93% | 94.15% |
| Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 3.69% | 4.56% | -1.60% | -0.80% | -12.53% | -13.08% | 69.32% | 239.52% |
| Divi's Laboratories DIVISLAB | 1.68T Large-cap | 7.29% | 1.28% | -11.38% | 16.08% | 0.52% | -0.61% | 70.86% | 89.42% |
| Innova Captab INNOVACAP | 47.41B Small-cap | -2.09% | -4.29% | -1.76% | 0.12% | -24.72% | 16.88% | 54.27% | 54.27% |
| Suven Life Sciences SUVEN | 47.99B Small-cap | 0.30% | -12.23% | -23.53% | 72.40% | 60.12% | 45.95% | 208.80% | 320.60% |
| Gujarat Themis GUJTHEM | 44.72B Small-cap | 5.04% | 8.07% | 20.17% | 66.93% | 70.32% | 89.42% | 89.42% | 89.42% |
Ownership & Short Interest
Insider Ownership
63.99%
Institutional Ownership
1.61%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2K
Average 90-Day Volume
3K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALBERTDAVD's 52-week high and low?
- In the last 52 weeks, Albert David reached a high of ₹1,540.00 (on December 11, 2024) and a low of ₹762.60 (on April 7, 2025).
- What is the market cap and P/E ratio for ALBERTDAVD?
- Curious about Albert David's size and valuation? Its market capitalization stands at 4.56B. When it comes to valuation, the P/E ratio (trailing twelve months) is 71.19, and the forward P/E (looking ahead) is N/A.
- Does ALBERTDAVD pay dividends? If so, what's the yield?
- Yes, Albert David is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.86%, and the company has paid an average of ₹17.50 per share annually over the past 3 years.
- Who are Albert David's main competitors or similar companies to consider before investing?
When looking at Albert David, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -13.08% 69.32% Divi's Laboratories
DIVISLAB1.68T Healthcare Drug Manufacturers - Specialty & Generic -0.61% 70.86% Innova Captab
INNOVACAP47.41B Healthcare Drug Manufacturers - Specialty & Generic 16.88% 54.27% Suven Life Sciences
SUVEN47.99B Healthcare Drug Manufacturers - Specialty & Generic 45.95% 208.80% Gujarat Themis
GUJTHEM44.72B Healthcare Drug Manufacturers - Specialty & Generic 89.42% 89.42% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Albert David Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Albert David's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.38%, the Debt to Equity ratio from the most recent quarter is 3.14, and its Gross Profit Margin stands at 64.18%.
- What is the recent revenue and earnings growth for ALBERTDAVD?
- Looking at Albert David's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -21.00%, and quarterly earnings saw a YoY growth of -57.90%.
- How much of ALBERTDAVD stock is held by insiders and institutions?
- Wondering who owns Albert David stock? Company insiders (like executives and directors) hold about 63.99% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.61%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.